Type1diabetes study: TranS-C Intervention Arm
Official title Thrive With Type 1 Diabetes 2026
ClinicalTrials.gov ID: NCT07522866
What this study is testing
- What it's testing
- The study wants to find out whether a cognitive behavioral intervention can improve lifestyle choices and glucose targets in adults with type 1 diabetes.
- Who it's for
- Adults who have type 1 diabetes.
- What's involved
- Participants will take part in a cognitive behavioral program, which may include sessions, homework, and monitoring of their daily habits and blood sugar levels.
- Time commitment
- The study will last for a set period (not specified in the source) and will involve scheduled visits or sessions as part of the intervention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 31 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Aged 31 to 75 years
- Type 1 Diabetes for at least 1 year
- One or more sleep health dimensions are out of range
You likely can't join if
- Non-English speaking
- Recent night shift work or transmeridian travel
- Life-limiting illness
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 31 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.